Andlauer Healthcare Group (TSE:AND) Price Target Lowered to C$51.00 at Eight Capital

Andlauer Healthcare Group (TSE:AND) had its price objective trimmed by Eight Capital from C$58.00 to C$51.00 in a report published on Friday morning, BayStreet.CA reports. The firm currently has a buy rating on the stock.

Several other equities research analysts also recently weighed in on AND. TD Securities reduced their price objective on shares of Andlauer Healthcare Group from C$54.00 to C$52.00 and set a buy rating for the company in a report on Monday, May 6th. Royal Bank of Canada reduced their price objective on shares of Andlauer Healthcare Group from C$43.00 to C$41.00 and set a sector perform rating for the company in a report on Monday, May 6th. Scotiabank reduced their price objective on shares of Andlauer Healthcare Group from C$46.00 to C$45.00 and set a sector perform rating for the company in a report on Friday. Stifel Nicolaus reduced their price objective on shares of Andlauer Healthcare Group from C$55.00 to C$52.00 and set a buy rating for the company in a report on Monday, May 6th. Finally, CIBC reduced their price objective on shares of Andlauer Healthcare Group from C$52.00 to C$50.00 and set an outperform rating for the company in a report on Monday, May 6th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of Moderate Buy and an average target price of C$48.57.

Andlauer Healthcare Group Stock Down 0.7 %

Andlauer Healthcare Group stock opened at C$41.55 on Friday. The company has a 50-day simple moving average of C$39.06 and a 200-day simple moving average of C$40.30. The firm has a market capitalization of C$809.39 million, a P/E ratio of 27.52 and a beta of 0.69. The company has a debt-to-equity ratio of 26.06, a quick ratio of 1.66 and a current ratio of 1.94. Andlauer Healthcare Group has a one year low of C$36.43 and a one year high of C$44.76.

Andlauer Healthcare Group (TSE:AND) last released its quarterly earnings results on Thursday, May 2nd. The company reported C$0.35 EPS for the quarter, missing the consensus estimate of C$0.53 by C($0.18). The firm had revenue of C$161.14 million for the quarter, compared to the consensus estimate of C$168.50 million. Andlauer Healthcare Group had a return on equity of 13.82% and a net margin of 10.02%. As a group, equities analysts expect that Andlauer Healthcare Group will post 1.6396243 earnings per share for the current year.

Andlauer Healthcare Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, July 15th. Shareholders of record on Friday, June 28th were issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 0.96%. The ex-dividend date of this dividend was Friday, June 28th. Andlauer Healthcare Group’s payout ratio is 23.84%.

Insider Buying and Selling at Andlauer Healthcare Group

In other Andlauer Healthcare Group news, Director Ronald Martin Skelton sold 1,500 shares of the company’s stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of C$40.87, for a total value of C$61,309.95. 1.43% of the stock is owned by corporate insiders.

Andlauer Healthcare Group Company Profile

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.